Mutant p53 in MDA-MB-231 breast cancer cells is stabilized by elevated phospholipase D activity and contributes to survival signals generated by phospholipase D

Oncogene

Volumn 25, Issue 55, 2006, Pages 7305-7310

  Hui, L ^a,b   Zheng, Y ^a   Yan, Y ^a   Bargonetti, J ^a   Foster, D A ^a  

^a CITY UNIVERSITY OF NEW YORK   (United States)

^b NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

Apoptosis; Breast cancer; p53; Phospholipase D; Survival signals

Indexed keywords

PHOSPHOLIPASE D; PROTEIN P53;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CELL STRAIN MCF 7; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

BREAST NEOPLASMS; CELL LINE, TUMOR; CELL SURVIVAL; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHOLIPASE D; PROTEIN KINASES; TUMOR SUPPRESSOR PROTEIN P53;

EID: 33751309077     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209735     Document Type: Article

References (44)

1. Asher G, Lotem J, Tsvetkov P, Reiss V, Sachs L, Shaul Y. (2003). Proc Natl Acad Sci USA 100: 15065-15070.
2. Bargonetti J, Manfredi JJ, Chen X, Marshak DR, Prives C. (1993). Genes Dev 7: 2565-2574.
3. Blagosklonny MV. (2000). FASEB J 14: 1901-1907.
4. Blandino G, Levine AJ, Oren M. (1999). Oncogene 18: 477-485.
5. Cadwell C, Zambetti GP. (2001). Gene 277: 15-30.
6. Chen Y, Zheng Y, Foster DA. (2003). Oncogene 22: 3937-3942.
7. Chen Y, Rodrik V, Foster DA. (2005). Oncogene 24: 672-679.
8. Deb SP, Munoz RM, Brown DR, Subler MA, Deb S. (1994). Oncogene 9: 1341-1349.
9. Dittmer D, Pati S, Zambetti G, Chu S, Teresky AK, Moore M et al. (1993). Nat Genet 4: 42-46.
10. Eliyahu D, Raz A, Gruss P, Givol D, Oren M. (1984). Nature 312: 646-649.
11. Fang Y, Vilella-Bach M, Bachman R, Flanigan A, Chen J. (2001). Science 294: 1942-1945.
12. Foster DA, Xu L. (2003). Mol Cancer Res 1: 789-800.
13. Foster DA. (2006). Curr Signal Transduction Ther 1: (in press).
14. Frazier MW, He X, Wang J, Gu Z, Cleveland JL, Zambetti GP. (1998). Mol Cell Biol 18: 3735-3743.
15. Hainaut P, Hollstein M. (2000). Adv Cancer Res 77: 81-137.
16. Hanahan D, Weinberg RA. (2000). Cell 100: 57-70.
17. Hinds PW, Finlay CA, Quartin RS, Baker SJ, Fearon ER, Vogelstein B et al. (1990). Cell Growth Differ 1: 571-580.
18. Hollstein M, Rice K, Greenblatt MS, Soussi T, Fuchs R, Sorlie T et al. (1994). Nucleic Acids Res 22: 3551-3555.
19. Hui L, Abbas T, Pielak R, Joseph T, Bargonetti J, Foster DA. (2004). Mol Cell Biol 24: 5677-5688.
20. Hui L, Rodrik V, Pielak RM, Zheng Y, Foster DA. (2005). J Biol Chem 280: 35829-35835.
21. Hsiao M, Low J, Dorn E, Ku D, Pattengale P, Yeargin J et al. (1994). Am J Pathol 145: 702-714.
22. Irwin MS. (2004). Cell Cycle 3: 319-323.
23. Jenkins JR, Rudge K, Currie GA. (1984). Nature 312: 651-654.
24. Katayose D, Gudas J, Nguyen H, Srivastava S, Cowan KH, Seth P. (1995). Clin Cancer Res 1: 889-897.
25. Kinzler KW, Vogelstein B. (1996). Cell 87: 159-170.
26. Kranenburg O, Verlaan I, Moolenaar WH. (1999). J Biol Chem 274: 35301-35304.
27. Lanyi A, Deb D, Seymour RC, Ludes-Meyers JH, Subler MA, Deb S. (1998). Oncogene 16: 3169-3176.
28. Levine AJ, Momand J, Finlay CA. (1991). Nature 351: 453-456.
29. Lu X, Errington J, Curtin NJ, Lunec J, Newell DR. (2001). Clin Cancer Res 7: 2114-2123.
30. Midgley CA, Lane DP. (1997). Oncogene 15: 1179-1189.
31. Moll UM, Petrenko O. (2003). Mol Cancer Res 1: 1001-1008.
32. Olivier M, Eeles R, Hollstein M, Khan MA, Harris CC, Hainaut P. (2002). Hum Mutat 19: 607-614.
33. Parada LF, Land H, Weinberg RA, Wolf D, Rotter V. (1984). Nature 312: 649-651.
34. Peng Y, Chen L, Li C, Lu W, Agrawal S, Chen J. (2001a). J Biol Chem 276: 6874-6878.
35. Peng Y, Chen L, Li C, Lu W, Chen J. (2001b). J Biol Chem 276: 40583-40590.
36. Preuss U, Kreutzfeld R, Scheidtmann KH. (2000). Int J Cancer 88: 162-171.
37. Scian MJ, Stagliano KE, Ellis MA, Hassan S, Bowman M, Miles MF et al. (2004). Cancer Res 64: 7447-7454.
38. Shen Y, Xu L, Foster DA. (2001). Mol Cell Biol 21: 595-602.
39. Strano S, Munarriz E, Rossi M, Cristofanelli B, Shaul Y, Castagnoli L et al. (2000). J Biol Chem 275: 29503-29512.
40. Strano S, Blandino G. (2003). Cell Cycle 2: 348-349.
41. van Oijen MG, Slootweg PJ. (2000). Clin Cancer Res 6: 2138-2145.
42. Wolf D, Harris N, Rotter V. (1984). Cell 38: 119-126.
43. Zambetti GP, Levine AJ. (1993). FASEB J 7: 855-865.
44. Zhong M, Shen Y, Zheng Y, Joseph T, Jackson D, Beychenok S et al. (2003). Biochem Biophys Res Comm 302: 615-619.